FRLN logo

FRLN Depreciation And Amortization

FRLN Annual D&A

$1.74 M
-$649.00 K-27.15%

31 December 2022

FRLN Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

FRLN Quarterly D&A

$386.00 K
-$47.00 K-10.85%

01 September 2023

FRLN Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

FRLN TTM D&A

$1.45 M
-$20.00 K-1.36%

01 September 2023

FRLN TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

FRLN Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-27.1%-4.9%-28.6%
3 y3 years+13.1%-17.2%+9.5%
5 y5 years+79.5%--

FRLN Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-27.2%-37.5%-39.2%

Freeline Therapeutics Holdings Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2023
-
$386.00 K(-10.9%)
$1.45 M(-1.4%)
June 2023
-
$433.00 K(+35.3%)
$1.47 M(-3.0%)
Mar 2023
-
$320.00 K(+1.6%)
$1.52 M(-12.7%)
Dec 2022
$1.74 M(-27.2%)
$315.00 K(-22.4%)
$1.74 M(-14.5%)
Sept 2022
-
$406.00 K(-15.2%)
$2.04 M(-8.2%)
June 2022
-
$479.00 K(-11.5%)
$2.22 M(-5.9%)
Mar 2022
-
$541.00 K(-11.5%)
$2.36 M(-1.3%)
Dec 2021
$2.39 M
-
-
Dec 2021
-
$611.00 K(+3.9%)
$2.39 M(+1.1%)
DateAnnualQuarterlyTTM
Sept 2021
-
$588.00 K(-4.9%)
$2.36 M(+5.4%)
June 2021
-
$618.00 K(+7.9%)
$2.24 M(+12.6%)
Mar 2021
-
$573.00 K(-2.1%)
$1.99 M(+4.1%)
Dec 2020
$1.91 M(+24.2%)
-
-
Dec 2020
-
$585.00 K(+25.5%)
$1.91 M(+44.1%)
Sept 2020
-
$466.00 K(+27.0%)
$1.33 M(+54.1%)
June 2020
-
$367.00 K(-25.9%)
$862.00 K(+74.1%)
Mar 2020
-
$495.00 K
$495.00 K
Dec 2019
$1.54 M(+58.8%)
-
-
Dec 2018
$970.00 K
-
-

FAQ

  • What is Freeline Therapeutics Holdings annual depreciation & amortization?
  • What is the all time high annual D&A for Freeline Therapeutics Holdings?
  • What is Freeline Therapeutics Holdings annual D&A year-on-year change?
  • What is Freeline Therapeutics Holdings quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Freeline Therapeutics Holdings?
  • What is Freeline Therapeutics Holdings quarterly D&A year-on-year change?
  • What is Freeline Therapeutics Holdings TTM depreciation & amortization?
  • What is the all time high TTM D&A for Freeline Therapeutics Holdings?
  • What is Freeline Therapeutics Holdings TTM D&A year-on-year change?

What is Freeline Therapeutics Holdings annual depreciation & amortization?

The current annual D&A of FRLN is $1.74 M

What is the all time high annual D&A for Freeline Therapeutics Holdings?

Freeline Therapeutics Holdings all-time high annual depreciation & amortization is $2.39 M

What is Freeline Therapeutics Holdings annual D&A year-on-year change?

Over the past year, FRLN annual depreciation & amortization has changed by -$649.00 K (-27.15%)

What is Freeline Therapeutics Holdings quarterly depreciation & amortization?

The current quarterly D&A of FRLN is $386.00 K

What is the all time high quarterly D&A for Freeline Therapeutics Holdings?

Freeline Therapeutics Holdings all-time high quarterly depreciation & amortization is $618.00 K

What is Freeline Therapeutics Holdings quarterly D&A year-on-year change?

Over the past year, FRLN quarterly depreciation & amortization has changed by -$20.00 K (-4.93%)

What is Freeline Therapeutics Holdings TTM depreciation & amortization?

The current TTM D&A of FRLN is $1.45 M

What is the all time high TTM D&A for Freeline Therapeutics Holdings?

Freeline Therapeutics Holdings all-time high TTM depreciation & amortization is $2.39 M

What is Freeline Therapeutics Holdings TTM D&A year-on-year change?

Over the past year, FRLN TTM depreciation & amortization has changed by -$583.00 K (-28.62%)